Scan X

Dukatech Solutions limited Company

Scan X

Tokenized micro-insurance integrated with community welfare groups to finance and track antibiotic access at community pharmacies.

Nairobi, Kenya

Kenya

For-profit, including B-Corp or similar models

We are addressing the fragmented, non-interoperable health insurance and distribution systems that hinder equitable access to quality-assured oral antibiotics at the community level in LMICs. In Kenya and across Sub-Saharan Africa, over 70% of first-line care is sought at neighborhood pharmacies, yet these are excluded from formal insurance schemes and pharmaceutical stock intelligence networks. As a result, pharmacies in low-income areas are often forced to stock substandard or falsified antibiotics—not due to negligence, but because patients paying out-of-pocket cannot afford originator brands, and affordable, quality alternatives are either unavailable or unviable. At the same time, over 85% of rural women in Kenya depend on informal savings groups like VSLAs for emergency health expenses—structures that lack actuarial intelligence, digital infrastructure, and integration with verified pharmaceutical systems. This creates a dual failure: volatile stock control and fragmented, opaque financing, both of which fuel irrational antibiotic use and resistance. Globally, antimicrobial resistance is projected to cause 39 million deaths over the next 25 years. By combining AI-driven inventory forecasting with tokenized micro-insurance embedded in trusted community financial systems, ScanX tackles the two systemic failures at the root of antibiotic misuse.

ScanX is a blockchain-enabled, AI-powered micro-health insurance and pharmaceutical logistics platform integrated into community-based welfare systems (VSLAs, CBOs, cooperatives). It tokenizes health contributions—starting from Ksh 15/day (~$0.12)—into smart contract-governed micro-insurance units, enabling members to access pre-approved, authenticated antibiotics at local pharmacies without paying out-of-pocket, with the ability to detect and route our fake antibiotics within the supply chain and prevent infiltration using AI and antibiotics indexing technology. Each token represents a programmable health entitlement, redeemable at digitally verified neighborhood pharmacies. When beneficiaries remain healthy or underutilize their coverage, unspent value is redistributed to the group as a low-interest revolving fund, incentivizing preventive behavior and building local capital. Simultaneously, ScanX deploys machine learning algorithms to predict antibiotic demand using prescription trends, seasonal disease patterns, and geospatial analytics. This drives real-time restocking at the pharmacy level, reducing supply volatility and eliminating the need to procure falsified or substandard antibiotics. Access, authentication, and financing are managed through a mobile-first, USSD-compatible interface. ScanX doesn’t digitize broken systems—it re-architects the last mile by embedding supply chain intelligence and equitable financing directly into community-governed care networks. https://www.youtube.com/watch?si=x70UvDiCTppQj_hM&v=AVH3VPgTRfI&feature=youtu.be

ScanX directly serves low-income women and children in rural and peri-urban communities, with an initial focus on Kenya, where over 85% of rural women lack health insurance and rely on informal welfare groups like VSLAs, cooperatives, and women-led CBOs for emergency healthcare support. These women face frequent stockouts of quality antibiotics, unaffordable out-of-pocket costs, and a high risk of substandard or falsified medicines, leading to poor health outcomes and deepening economic vulnerability. ScanX integrates blockchain-based micro-insurance into these trusted welfare structures, allowing members to contribute from as little as Ksh 15/day (~$0.12) toward health coverage, redeemable at verified local pharmacies. This is coupled with AI-driven inventory forecasting, ensuring that essential antibiotics are consistently available where they are needed most. The solution reduces out-of-pocket medical spending, prevents delays in treatment, and protects women and children from financial shocks caused by health emergencies. Over a 12-month pilot, ScanX aims to serve 10,000 users across 500 welfare groups, reduce antibiotic stockouts by 60%, and increase access to authenticated medications by 70%—transforming how underserved communities finance and access life-saving treatment.